Martell Christopher - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 9, 2022, Martell Christopher's relationship to Candel Therapeutics, Inc. (CADL) is Director, and currently has 152,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CADL insiders.
Data Source: SEC.
Martell Christopher - Insider Non-Derivative Transactions of CADL Common Stock
Martell Christopher - Insider Non-Derivative Transactions at CADL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 10, 2022 | P -- (Common Stock) | 23950 | 1.92 | 152000 |
| Dec 9, 2022 | P -- (Common Stock) | 3050 | 1.68 | 128050 |